--- Content provided by FirstRanker.com ---
DECEMBER 2017
HEMATOLOGY
PAPER-III
--- Content provided by FirstRanker.com ---
HEM/D/17/48/111
Time : 3 hours
--- Content provided by FirstRanker.com ---
Max. Marks : 100
Attempt all questions in order.
Each question carries 10 marks.
--- Content provided by FirstRanker.com ---
Read the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
--- Content provided by FirstRanker.com ---
Indicate the question number correctly for the answer in the margin space
Answer all the parts of a single question together.
Start the question to a question on a fresh page or leave adequate space between two answers.
--- Content provided by FirstRanker.com ---
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
--- Content provided by FirstRanker.com ---
WHO classification of acute leukemia 2016: 4+3+3
- What are the changes in ALL?
- What are germ line malignancy?
- How this classification is better than 2008 classification?
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Thalassemia: 3+3+4
- Monitoring iron overload
- Long term endocrinological complications and their management
- Hematopoietic stem cell transplant in-thalassemia
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Allogenic hematopoietic stem cell transplantation (HSCT): 4+2+4
--- Content provided by FirstRanker.com ---
- Haploidentical HSCT
- Role of killer immunoglobulin like receptors.
- Its role in therapy of AML.
--- Content provided by FirstRanker.com ---
- Classification of vWD 3+3+4
- Diagnosis of subtypes
- Management of vWD
--- Content provided by FirstRanker.com ---
Hemophilia: 3+3+2+2
- Diagnosis of coagulations factor defects.
- Newer FVIII replacement options.
- How do you decide which factors to use?
- Management of hemophiliac joint arthropathy
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Hodgkin’s lymphoma: 3+3+4
- Role of PET-CT.
- Risk adapted approach in the management of Hodgkin’s lymphoma.
- Place of hematopoietic stem cell transplantation in the management algorithm.
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
--- Content provided by FirstRanker.com ---
DECEMBER 2017
--- Content provided by FirstRanker.com ---
- Lab approach to diagnose inherited thrombophilia. 3+4+3
- ISTH guidelines for management of anti-phospholipic syndrome
- Newer anti coagulants
--- Content provided by FirstRanker.com ---
- Causes of acquired platelet dyfunctions. 3+4+3
- Newer anti platelet agents
- Lab monitoring of anti platelet agents.
--- Content provided by FirstRanker.com ---
CML: 6+2+2
- How will you manage CML patient?
- Imatinib resistance.
- International standardization of BCR-ABL.
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
- Approach to treatment with newer agents in multiple myeloma 4+3+3
- Therapeutic strategies in sickle cell anemia
- Optimizing therapy in follicular lymphoma
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
--- Content provided by FirstRanker.com ---
This download link is referred from the post: DNB 2017 Dec Previous Question Papers-(Diplomate of National Board) Under NBE